using ai to segment and classify bone marrow cells in patients with aml
Published 1 year ago • 120 plays • Length 8:05Download video MP4
Download video MP3
Similar videos
-
1:26
low bone marrow cellularity predicts hematologic aes to cpx-351 in aml
-
1:17
using an ai model to quantify under-utilization of allosct for aml in the uk
-
2:33
what can artificial intelligence bring to the diagnosis and management of mds?
-
3:39
applications of ai in hemonc: improving diagnosis & predicting outcomes and response to therapy
-
2:12
barriers to the implementation and standardization of ai in the clinic
-
7:25
ai in hematology: advances, challenges, and future applications
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
4:31
labmt: impact of treatment prior to allogenic hct in mds
-
1:48
the evolving role of ai in mpns
-
4:39
aml & mds: mac or ric?
-
1:52
the need to train hcps and researches to use ai & machine learning in healthcare
-
4:45
phase ib/ii multi-arm study of combinations of novel agents in r/r aml
-
2:57
why do we need ai in the hematology clinic?
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
1:47
shared treatment decision-making
-
1:49
bringing precision medicine and mrd into clinical strategies
-
6:06
the role of ai in medicine and how acceptance and trust in ai strategies can be fostered
-
0:45
ai-enabled automatic cmf segmentation | mimics innovation suite 24
-
2:28
considerations for building ai models in healthcare